Large-scale testing (Phase 3)Study completedNCT01391546
What this trial is testing
Immunogenicity and Safety Study of ZOSTAVAX Administered by Intramuscular or Subcutaneous Route to Participants Aged From 50 Years Old (V211-045)
Who this might be right for
Herpes Zoster
Merck Sharp & Dohme LLC 354